Refine Results
- Products
-
Product Category
- Applications and Industries
-
Solution Category
- Services
- Content Type
-
Content Type
- Analysis Technique
-
- Analyzed With
-
Analyzed With
- Chemical Group
-
Chemical Group
- Compounds
-
Compounds
- Detection Technique
-
- Injection Technique
-
- Instrument
-
Instrument
- Method
- Outer DIameter
-
Outer DIameter
- Unit Quantity
-
Unit Quantity
- Analysis Platform
-
Analysis Platform
- Spectroscopy Instrument Compatibility
-
Spectroscopy Instrument Compatibility
- Language
-
Language
190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073313, Certificate of Analysis
- Created: 25 Jan 2021
- 336 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073320, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073321, Certificate of Analysis
- Created: 25 Jan 2021
- 354 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073323, Certificate of Analysis
- Created: 25 Jan 2021
- 354 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0011207335, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073319, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0011207338, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073322, Certificate of Analysis
- Created: 25 Jan 2021
- 354 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073315, Certificate of Analysis
- Created: 25 Jan 2021
- 354 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0011207332, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0011207334, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073310, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0011207337, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073312, Certificate of Analysis
- Created: 25 Jan 2021
- 354 KB
5190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0011207339, Certificate of Analysis
- Created: 25 Jan 2021
- 359 KB
190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073317, Certificate of Analysis
- Created: 25 Jan 2021
- 335 KB
190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073316, Certificate of Analysis
- Created: 25 Jan 2021
- 335 KB
190-9770, Pharma Internal Standard 1, in 2% HNO3, tr. HF, Lot 0112073318, Certificate of Analysis
- Created: 25 Jan 2021
- 336 KB
190-8341, Pre-Mixed GFAA Matrix Modifier 1000 µg/mL Pd and 600 µg/mL Mg(NO3)2 in 2% HNO3, Lot 0011129638, Certificate of Analysis
- Created: 21 Jan 2021
- 335 KB
5190-8341, Pre-Mixed GFAA Matrix Modifier 1000 µg/mL Pd and 600 µg/mL Mg(NO3)2 in 2% HNO3, Lot 0011129639, Certificate of Analysis
- Created: 21 Jan 2021
- 349 KB